MedTrace Logo

Detecting Chronic Subdural Hematoma With Microwave Technology

NCT02282228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-08-23

No results posted yet for this study

Summary

An open study evaluating the sensitivity and specificity of a microwave-based device, Medfield Strokefinder MD100, to detect chronic subdural hematoma, by comparing measurements on patients recruited for surgery of chronic subdural hematoma to an age- and gender-matched group of healthy volunteers.

Conditions

  • Chronic Subdural Hematoma
  • Healthy Volunteers

Interventions

DEVICE

Medfield Strokefinder MD100

Measurement with Medfield Strokefinder MD100.

Sponsors & Collaborators

  • Medfield Diagnostics

    collaborator INDUSTRY

  • Chalmers University of Technology

    collaborator OTHER

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Thomas Skoglund, MD, PhD · Sahlgrenska University Hospital, Department of Neurosurgery

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02282228 on ClinicalTrials.gov